Drugs Made In America Acquisition Corp.
DMAAR- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $1.27M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Drugs Made In America Acquisition Corp. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +19 vs. Q4 2024
- Shares held
- 14.2M
- +14.2M vs. Q4 2024
- Total value
- $1.72M
- +$1.72M vs. Q4 2024
- New holders
- 19
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $1.27M |
| Q1 2026 | 35 | $872.3K |
| Q4 2025 | 32 | $3.02M |
| Q3 2025 | 32 | $3.71M |
| Q2 2025 | 24 | $2.22M |
| Q1 2025 | 19 | $1.72M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 1,900,000 | $247.0K | 0.01% | +1,900,000 | New |
| Hudson Bay Capital Management LP | 1,800,000 | $234.0K | 0.00% | +1,800,000 | New |
| Harraden Circle Investments, LLC | 1,500,000 | $195.0K | 0.09% | +1,500,000 | New |
| Glazer Capital, LLC | 1,300,000 | $169.0K | 0.01% | +1,300,000 | New |
| Aristeia Capital LLC | 900,000 | $117.0K | 0.00% | +900,000 | New |
| Highbridge Capital Management LLC | 850,000 | $110.5K | 0.00% | +850,000 | New |
| Mangrove Partners | 850,000 | $110.5K | 0.01% | +850,000 | New |
| Wolverine Asset Management LLC | 603,038 | $78.4K | 0.00% | +603,038 | New |
| Atw Spac Management LLC | 570,000 | $74.1K | 0.12% | +570,000 | New |
| Clear Street LLC | 550,176 | $71.5K | 0.00% | +550,176 | New |
| Cantor Fitzgerald, L. P. | 500,000 | $65.0K | 0.00% | +500,000 | New |
| CNH Partners LLC | 500,000 | $65.0K | 0.00% | +500,000 | New |
| LMR Partners LLP | 500,000 | $65.0K | 0.00% | +500,000 | New |
| Whitebox Advisors LLC | 400,000 | $52.0K | 0.00% | +400,000 | New |
| Schonfeld Strategic Advisors LLC | 200,000 | $26.0K | 0.00% | +200,000 | New |
| Mizuho Securities USA LLC | 209,897 | $21.0K | 0.00% | +209,897 | New |
| Quarry LP | 150,000 | $19.5K | 0.01% | +150,000 | New |
| Warberg Asset Management LLC | 18,443 | $2.40K | 0.00% | +18,443 | New |
| Crossingbridge Advisors, LLC | 850,000 | – | – | +850,000 | New |